Free Trial

Xponance Inc. Sells 12,536 Shares of The Allstate Corporation (NYSE:ALL)

Allstate logo with Finance background

Xponance Inc. decreased its holdings in The Allstate Corporation (NYSE:ALL - Free Report) by 22.8% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 42,426 shares of the insurance provider's stock after selling 12,536 shares during the period. Xponance Inc.'s holdings in Allstate were worth $8,785,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in the business. Vanguard Group Inc. lifted its holdings in shares of Allstate by 1.2% in the 4th quarter. Vanguard Group Inc. now owns 32,635,424 shares of the insurance provider's stock valued at $6,291,783,000 after acquiring an additional 389,426 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its stake in Allstate by 2.4% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 9,334,926 shares of the insurance provider's stock worth $1,799,681,000 after purchasing an additional 218,771 shares during the last quarter. Bank of America Corp DE lifted its stake in Allstate by 157.9% in the fourth quarter. Bank of America Corp DE now owns 6,591,138 shares of the insurance provider's stock worth $1,270,705,000 after purchasing an additional 4,035,629 shares during the last quarter. Geode Capital Management LLC lifted its stake in Allstate by 3.1% in the fourth quarter. Geode Capital Management LLC now owns 6,419,728 shares of the insurance provider's stock worth $1,236,060,000 after purchasing an additional 191,147 shares during the last quarter. Finally, GQG Partners LLC lifted its stake in Allstate by 64.1% in the fourth quarter. GQG Partners LLC now owns 4,316,516 shares of the insurance provider's stock worth $832,181,000 after purchasing an additional 1,685,694 shares during the last quarter. Institutional investors own 76.47% of the company's stock.

Analysts Set New Price Targets

Several analysts have issued reports on ALL shares. Keefe, Bruyette & Woods raised their price objective on shares of Allstate from $235.00 to $237.00 and gave the stock an "outperform" rating in a research note on Wednesday. William Blair started coverage on shares of Allstate in a research note on Friday, June 6th. They issued a "sector outperform" rating for the company. Barclays raised their price objective on shares of Allstate from $172.00 to $188.00 and gave the stock an "underweight" rating in a research note on Monday, July 7th. Wall Street Zen lowered shares of Allstate from a "buy" rating to a "hold" rating in a research report on Saturday. Finally, Evercore ISI raised their target price on shares of Allstate from $227.00 to $230.00 and gave the stock an "outperform" rating in a research report on Thursday, May 1st. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $227.07.

Check Out Our Latest Stock Report on Allstate

Allstate Stock Performance

Shares of ALL stock opened at $193.20 on Friday. The firm has a market cap of $51.16 billion, a price-to-earnings ratio of 13.20, a PEG ratio of 1.01 and a beta of 0.33. The company's 50 day moving average is $200.99 and its 200 day moving average is $196.66. The company has a quick ratio of 0.40, a current ratio of 0.40 and a debt-to-equity ratio of 0.40. The Allstate Corporation has a 52-week low of $161.82 and a 52-week high of $213.18.

Allstate (NYSE:ALL - Get Free Report) last issued its quarterly earnings results on Wednesday, April 30th. The insurance provider reported $3.53 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $3.98 by ($0.45). The business had revenue of $14.30 billion for the quarter, compared to analyst estimates of $16.41 billion. Allstate had a return on equity of 24.62% and a net margin of 6.19%. The business's revenue for the quarter was up 7.8% on a year-over-year basis. During the same period in the previous year, the company posted $5.13 earnings per share. On average, sell-side analysts anticipate that The Allstate Corporation will post 18.74 EPS for the current fiscal year.

Allstate Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, July 1st. Stockholders of record on Monday, June 9th were issued a dividend of $1.00 per share. This represents a $4.00 dividend on an annualized basis and a dividend yield of 2.07%. The ex-dividend date was Monday, June 9th. Allstate's dividend payout ratio (DPR) is presently 27.32%.

Allstate Profile

(Free Report)

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.

Featured Articles

Institutional Ownership by Quarter for Allstate (NYSE:ALL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Allstate Right Now?

Before you consider Allstate, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.

While Allstate currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Hot Growth Stocks to Watch Right Now!
Don’t Miss These Top 3 Defense Stocks Set To Gain
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines